- Home
- TVRD vs NOTV Comparison
TVRD vs NOTV Comparison
Compare TVRD & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVRD
- NOTV
- Stock Information
- Founded
- TVRD 2017
- NOTV 1974
- Country
- TVRD United States
- NOTV United States
- Employees
- TVRD N/A
- NOTV N/A
- Industry
- TVRD Biotechnology: Pharmaceutical Preparations
- NOTV Biotechnology: Pharmaceutical Preparations
- Sector
- TVRD Health Care
- NOTV Health Care
- Exchange
- TVRD Nasdaq
- NOTV Nasdaq
- Market Cap
- TVRD 170.7M
- NOTV 137.5M
- IPO Year
- TVRD N/A
- NOTV 1997
- Fundamental
- Price
- TVRD $17.47
- NOTV $1.61
- Analyst Decision
- TVRD
- NOTV Strong Buy
- Analyst Count
- TVRD 0
- NOTV 3
- Target Price
- TVRD N/A
- NOTV $5.92
- AVG Volume (30 Days)
- TVRD 14.4K
- NOTV 1.2M
- Earning Date
- TVRD 05-21-2025
- NOTV 05-09-2025
- Dividend Yield
- TVRD N/A
- NOTV N/A
- EPS Growth
- TVRD N/A
- NOTV N/A
- EPS
- TVRD N/A
- NOTV N/A
- Revenue
- TVRD N/A
- NOTV $475,114,000.00
- Revenue This Year
- TVRD N/A
- NOTV $6.07
- Revenue Next Year
- TVRD N/A
- NOTV $5.74
- P/E Ratio
- TVRD N/A
- NOTV N/A
- Revenue Growth
- TVRD N/A
- NOTV N/A
- 52 Week Low
- TVRD $8.14
- NOTV $1.15
- 52 Week High
- TVRD $31.32
- NOTV $6.48
- Technical
- Relative Strength Index (RSI)
- TVRD N/A
- NOTV 37.75
- Support Level
- TVRD N/A
- NOTV $1.15
- Resistance Level
- TVRD N/A
- NOTV $1.85
- Average True Range (ATR)
- TVRD 0.00
- NOTV 0.44
- MACD
- TVRD 0.00
- NOTV -0.04
- Stochastic Oscillator
- TVRD 0.00
- NOTV 26.44
About NOTV Inotiv Inc.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.